Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Taiwan - Delayed Quote TWD

Bora Pharmaceuticals Co., LTD. (6472.TW)

Compare
692.00
-6.00
(-0.86%)
At close: April 2 at 1:30:33 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,245,907
19,245,907
14,200,068
10,494,470
4,899,885
Cost of Revenue
11,535,632
11,535,632
7,208,830
7,581,695
3,228,107
Gross Profit
7,710,275
7,710,275
6,991,238
2,912,775
1,671,778
Operating Expense
4,327,654
4,327,654
1,742,099
990,599
625,787
Operating Income
3,382,621
3,382,621
5,249,139
1,922,176
1,045,991
Net Non Operating Interest Income Expense
-479,722
-479,722
-171,239
-108,727
-53,616
Pretax Income
4,954,981
4,954,981
4,064,146
1,840,001
1,023,968
Tax Provision
914,578
914,578
992,225
438,476
274,232
Net Income Common Stockholders
3,939,009
3,939,009
3,030,142
1,391,916
749,736
Diluted NI Available to Com Stockholders
3,939,009
3,939,009
3,030,142
1,391,916
749,736
Basic EPS
38.69
--
30.20
14.26
7.73
Diluted EPS
35.82
--
29.39
14.13
7.71
Basic Average Shares
101,813
--
100,341
97,600
77,852.38
Diluted Average Shares
112,022
--
103,560
98,698
78,083.58
Total Expenses
15,863,286
15,863,286
8,950,929
8,572,294
3,853,894
Net Income from Continuing & Discontinued Operation
3,939,009
3,939,009
3,030,142
1,391,916
749,736
Normalized Income
2,512,767.37
2,512,767.37
3,030,142
1,391,916
749,736
Interest Expense
479,722
479,722
171,239
108,727
53,616
Net Interest Income
-479,722
-479,722
-171,239
-108,727
-53,616
EBIT
5,434,703
5,434,703
4,235,385
1,948,728
1,077,584
EBITDA
6,461,032
6,461,032
4,841,671
2,273,914
1,287,749
Reconciled Cost of Revenue
11,535,632
11,535,632
7,208,830
7,581,695
3,228,107
Reconciled Depreciation
1,026,329
1,026,329
606,286
325,186
210,165
Net Income from Continuing Operation Net Minority Interest
3,939,009
3,939,009
3,030,142
1,391,916
749,736
Total Unusual Items Excluding Goodwill
1,749,083
1,749,083
--
--
--
Total Unusual Items
1,749,083
1,749,083
--
--
--
Normalized EBITDA
4,711,949
4,711,949
4,841,671
2,273,914
1,287,749
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
322,841.37
322,841.37
--
--
--
12/31/2021 - 12/11/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6446.TW PharmaEssentia Corporation
536.00
+1.13%
 
1795.TW Lotus Pharmaceutical Co., Ltd.
232.00
-0.85%
 
4746.TW Formosa Laboratories, Inc.
67.80
+2.73%
 
3705.TW YungShin Global Holding Corporation
58.80
+1.03%
 
4105.TWO TTY Biopharm Company Limited
75.70
+2.16%
 
4114.TWO Synmosa Biopharma Corporation
33.95
+0.15%
 
4123.TWO Center Laboratories, Inc.
38.05
+0.26%
 
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
60.50
0.00%
 
6785.TWO Alar Pharmaceuticals Inc.
133.00
+1.53%
 
1707.TW Grape King Bio Ltd
142.00
0.00%